Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
NCT00224289
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Latanoprost 0.005%
Sponsor
Yale University
Collaborators
[object Object]